We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
FCDO travel advice for Ecuador. Includes safety and security, insurance, entry requirements and legal differences.
How to use a randomised controlled trial to evaluate your digital health product.
Help available and steps you should take if you have a medical emergency or are hospitalised abroad, including for planned treatment.
Automation is the future for manufacturing stem cells, says the Head of the Medicines and Healthcare products Regulatory Agency’s UK Stem Cell Bank (UKSCB) on its 20th Anniversary.
FCDO travel advice for Colombia. Includes safety and security, insurance, entry requirements and legal differences.
How UK citizens or residents can get healthcare when visiting countries or territories outside the EU where the UK has reciprocal healthcare agreements.
Apply for a Very High Cost Case (VHCC) contract.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
How to account for VAT on goods and services provided by registered health professionals, including doctors, dentists, nurses and pharmacists.
How to use a quasi-experimental study to evaluate your digital health product.
FCDO travel advice for USA. Includes safety and security, insurance, entry requirements and legal differences.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
The CMA acts to help NHS patients access combination therapies used to treat serious medical conditions.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
The review will examine the harm that drugs cause and look at prevention, treatment and recovery.
Helping public health practitioners conducting evaluations – using economic evaluation to identify the value gained from an intervention.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.